Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19394651rdf:typepubmed:Citationlld:pubmed
pubmed-article:19394651lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:19394651lifeskim:mentionsumls-concept:C2239176lld:lifeskim
pubmed-article:19394651lifeskim:mentionsumls-concept:C0449258lld:lifeskim
pubmed-article:19394651lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:19394651pubmed:issue1lld:pubmed
pubmed-article:19394651pubmed:dateCreated2009-12-16lld:pubmed
pubmed-article:19394651pubmed:abstractTextThe hypervascular nature of hepatocellular carcinoma (HCC) has led a number of investigators to explore the potential of anti-angiogenic therapy for this cancer. We aimed to investigate the efficacy of anti-angiogenetic therapy for the prevention and treatment of HCC.lld:pubmed
pubmed-article:19394651pubmed:languageenglld:pubmed
pubmed-article:19394651pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19394651pubmed:citationSubsetIMlld:pubmed
pubmed-article:19394651pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19394651pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19394651pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19394651pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19394651pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19394651pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19394651pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19394651pubmed:statusMEDLINElld:pubmed
pubmed-article:19394651pubmed:monthJanlld:pubmed
pubmed-article:19394651pubmed:issn1095-8673lld:pubmed
pubmed-article:19394651pubmed:authorpubmed-author:YanagaKatsuhi...lld:pubmed
pubmed-article:19394651pubmed:authorpubmed-author:SakamotoTaroTlld:pubmed
pubmed-article:19394651pubmed:authorpubmed-author:IshiiYujiYlld:pubmed
pubmed-article:19394651pubmed:authorpubmed-author:ItoRysukeRlld:pubmed
pubmed-article:19394651pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19394651pubmed:volume158lld:pubmed
pubmed-article:19394651pubmed:ownerNLMlld:pubmed
pubmed-article:19394651pubmed:authorsCompleteYlld:pubmed
pubmed-article:19394651pubmed:pagination69-76lld:pubmed
pubmed-article:19394651pubmed:meshHeadingpubmed-meshheading:19394651...lld:pubmed
pubmed-article:19394651pubmed:meshHeadingpubmed-meshheading:19394651...lld:pubmed
pubmed-article:19394651pubmed:meshHeadingpubmed-meshheading:19394651...lld:pubmed
pubmed-article:19394651pubmed:meshHeadingpubmed-meshheading:19394651...lld:pubmed
pubmed-article:19394651pubmed:meshHeadingpubmed-meshheading:19394651...lld:pubmed
pubmed-article:19394651pubmed:meshHeadingpubmed-meshheading:19394651...lld:pubmed
pubmed-article:19394651pubmed:meshHeadingpubmed-meshheading:19394651...lld:pubmed
pubmed-article:19394651pubmed:meshHeadingpubmed-meshheading:19394651...lld:pubmed
pubmed-article:19394651pubmed:meshHeadingpubmed-meshheading:19394651...lld:pubmed
pubmed-article:19394651pubmed:meshHeadingpubmed-meshheading:19394651...lld:pubmed
pubmed-article:19394651pubmed:meshHeadingpubmed-meshheading:19394651...lld:pubmed
pubmed-article:19394651pubmed:meshHeadingpubmed-meshheading:19394651...lld:pubmed
pubmed-article:19394651pubmed:meshHeadingpubmed-meshheading:19394651...lld:pubmed
pubmed-article:19394651pubmed:year2010lld:pubmed
pubmed-article:19394651pubmed:articleTitleAnti-angiogenic therapy on hepatocellular carcinoma development and progression.lld:pubmed
pubmed-article:19394651pubmed:affiliationDepartment of Surgery, Jikei University School of Medicine, Minato-ku, Tokyo, Japan. yujiyunayuta@jikei.ac.jplld:pubmed
pubmed-article:19394651pubmed:publicationTypeJournal Articlelld:pubmed